Immune checkpoint inhibitors are a class of drugs that help to unleash the body's immune system to fight cancer. They work by blocking proteins that inhibit the immune system, thus allowing T-cells to destroy cancer cells more effectively. Common targets for these inhibitors include PD-1, PD-L1, and CTLA-4.